Happy Sunday everyone! Today, I talk about: -#BIIB/Eisai and their decision to continue trials with compounds that reduce brain amyloid beta -ESSENCE interim data from #SRPT -The #VKTX abstract release and upgrade -More good news about #AMRN This is not investment advice, so do your own due diligence! www.breakingbiotech.com breakingbiotech #biotech